| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
SNTA1 |
SNTA1, SNT1: Alpha-1-syntrophin |
7.992 |
Evidence |
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
SNTA1 |
SNTA1, SNT1: Alpha-1-syntrophin |
7.992 |
Evidence |
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
MAP3K10 |
MAP3K10, MLK2, MST: Mitogen-activated protein kinase kinase kinase 10 |
7.992 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
PAK7 |
PAK7, KIAA1264, PAK5: Serine/threonine-protein kinase PAK 7 |
7.992 |
Evidence |
|
| SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
LAMA2 |
LAMA2: Uncharacterized protein LAMA2 |
7.992 |
Evidence |
|
| HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
7.992 |
Evidence |
|
| YY1 |
YY1: Transcriptional repressor protein YY1 |
ZBTB16 |
ZBTB16, PLZF, ZNF145: Zinc finger and BTB domain-containing protein 16 |
7.992 |
Evidence |
|
| MYL9 |
MYL9, MLC2, MRLC1, MYRL2: Myosin regulatory light chain 2, smooth muscle isoform |
LYN |
LYN: Tyrosine-protein kinase Lyn |
7.992 |
Evidence |
|
| JUND |
JUND: Transcription factor jun-D |
ELK1 |
ELK1: ETS domain-containing protein Elk-1 |
7.992 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
LYN |
LYN: Tyrosine-protein kinase Lyn |
7.992 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
MYL9 |
MYL9, MLC2, MRLC1, MYRL2: Myosin regulatory light chain 2, smooth muscle isoform |
7.992 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
PAK7 |
PAK7, KIAA1264, PAK5: Serine/threonine-protein kinase PAK 7 |
7.992 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
MYL9 |
MYL9, MLC2, MRLC1, MYRL2: Myosin regulatory light chain 2, smooth muscle isoform |
7.992 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
MST1R |
MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor |
7.992 |
Evidence |
|
| DAB1 |
DAB1: Disabled homolog 1 |
SYK |
SYK: Tyrosine-protein kinase SYK |
7.992 |
Evidence |
|
| DAB1 |
DAB1: Disabled homolog 1 |
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
7.992 |
Evidence |
|
| ROCK2 |
ROCK2, KIAA0619: Rho-associated protein kinase 2 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
7.992 |
Evidence |
|
| SORBS3 |
SORBS3, SCAM1: Vinexin |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
7.992 |
Evidence |
|
| CASQ2 |
CASQ2: Calsequestrin-2 precursor |
PDIA3 |
PDIA3, ERP57, ERP60, GRP58: Protein disulfide-isomerase A3 precursor |
7.992 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
CD2AP |
CD2AP: CD2-associated protein |
7.992 |
Evidence |
|
| HTR2A |
HTR2A, HTR2: 5-hydroxytryptamine receptor 2A |
EPB41L3 |
EPB41L3, DAL1, KIAA0987: Band 4.1-like protein 3 |
7.99 |
Evidence |
|
| C9 |
C9: Complement component C9 precursor [Contains: Complement component C9a; Compl |
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
7.987 |
Evidence |
|
| CTTN |
CTTN, EMS1: Src substrate cortactin |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
7.977 |
Evidence |
|
| CTTN |
CTTN, EMS1: Src substrate cortactin |
LYN |
LYN: Tyrosine-protein kinase Lyn |
7.977 |
Evidence |
|
| CTTN |
CTTN, EMS1: Src substrate cortactin |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
7.977 |
Evidence |
|